Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose

Overview of attention for article published in Investigational New Drugs, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER

Application WO-2021080428-A1

World Intellectual Property Organisation (WIPO)